Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A pooled testing strategy for identifying SARS-CoV-2 at low prevalence.
Mutesa L, Ndishimye P, Butera Y, Souopgui J, Uwineza A, Rutayisire R, Ndoricimpaye EL, Musoni E, Rujeni N, Nyatanyi T, Ntagwabira E, Semakula M, Musanabaganwa C, Nyamwasa D, Ndashimye M, Ujeneza E, Mwikarago IE, Muvunyi CM, Mazarati JB, Nsanzimana S, Turok N, Ndifon W. Mutesa L, et al. Among authors: ntagwabira e. Nature. 2021 Jan;589(7841):276-280. doi: 10.1038/s41586-020-2885-5. Epub 2020 Oct 21. Nature. 2021. PMID: 33086375 Free article.
Author Correction: A pooled testing strategy for identifying SARS-CoV-2 at low prevalence.
Mutesa L, Ndishimye P, Butera Y, Souopgui J, Uwineza A, Rutayisire R, Ndoricimpaye EL, Musoni E, Rujeni N, Nyatanyi T, Ntagwabira E, Semakula M, Musanabaganwa C, Nyamwasa D, Ndashimye M, Ujeneza E, Mwikarago IE, Muvunyi CM, Mazarati JB, Nsanzimana S, Turok N, Ndifon W. Mutesa L, et al. Among authors: ntagwabira e. Nature. 2021 Jul;595(7865):E3. doi: 10.1038/s41586-021-03630-z. Nature. 2021. PMID: 34135513 Free PMC article. No abstract available.
Efficacy of artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria among children in Rwanda: an open-label, randomized controlled trial.
Uwimana A, Penkunas MJ, Nisingizwe MP, Warsame M, Umulisa N, Uyizeye D, Musanabaganwa C, Munyaneza T, Ntagwabira E, Hakizimana D, Muvunyi CM, Kayobotsi C, Kabera M, Murindahabi M, Mbituyumuremyi A. Uwimana A, et al. Among authors: ntagwabira e. Trans R Soc Trop Med Hyg. 2019 Jun 1;113(6):312-319. doi: 10.1093/trstmh/trz009. Trans R Soc Trop Med Hyg. 2019. PMID: 30892640 Clinical Trial.
Innovative strategies for a successful SLMTA country programme: The Rwanda story.
Nzabahimana I, Sebasirimu S, Gatabazi JB, Ruzindana E, Kayobotsi C, Linde MK, Mazarati JB, Ntagwabira E, Serumondo J, Dahourou GA, Gatei W, Muvunyi CM. Nzabahimana I, et al. Among authors: ntagwabira e. Afr J Lab Med. 2014 Nov 3;3(2):217. doi: 10.4102/ajlm.v3i2.217. eCollection 2014. Afr J Lab Med. 2014. PMID: 29043189 Free PMC article.
Genomic and transmission dynamics of the 2024 Marburg Virus Outbreak in Rwanda.
Butera Y, Mutesa L, Parker E, Muvunyi R, Umumararungu E, Ayitewala A, Musabyimana JP, Olono A, Sesonga P, Ogunsanya O, Kabalisa E, Adedokun O, Gahima N, Irankunda L, Mutezemariya C, Niyonkuru R, Uwituze A, Uwizera I, Kagame J, Umugwaneza A, Rwabuhihi J, Umwanankabandi F, Mbonitegeka V, Ntagwabira E, Kayigi E, Izuwayo G, Murenzi H, Mukankwiro T, Tuyiringire N, Uwimana JMV, Gasengayire A, Sindayiheba R, Onyeugo GU, Aragaw M, Gitundu L, Bigirimana R, Fallah M, Ejikeme A, Sembuche S, Kabanda A, Mugisha JC, Francis EES, Gashema P, Ndayisenga J, Rugamba A, Kanyabwisha F, Murenzi G, Happi A, Ngabonziza JCS, Gashegu M, Ahmed A, Bigirimana N, Rwagasore E, Semakula M, Rwabihama JP, Musanabaganwa C, Seruyange E, Nkeshimana M, Twagirumugabe T, Turatsinze D, Remera E, Gahamanyi N, Tessema SK, Mukagatare I, Nsanzimana S, Happi C, Muvunyi CM. Butera Y, et al. Among authors: ntagwabira e. Nat Med. 2024 Dec 16. doi: 10.1038/s41591-024-03459-9. Online ahead of print. Nat Med. 2024. PMID: 39681304